Literature DB >> 8749912

Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease).

J C Emond1, P F Whitington.   

Abstract

Progressive familial intrahepatic cholestasis (PFIC) presents in early childhood with pruritus, jaundice, hepatomegaly, and growth failure. Medical therapy is unsuccessful, with progression from cholestasis to hepatic fibrosis, cirrhosis, and ultimately death before the age of 10 years. Because of evidence that biliary diversion can arrest or reverse progression to hepatic fibrosis, we have used partial biliary diversion (PBD) as primary therapy in PFIC, reserving orthotopic liver transplantation (OLT) for children who have progressive disease or established cirrhosis. Seventeen children with PFIC (aged 2 months to 19 years) have been treated. PBD was performed in eight cases. In these procedures, a 10-cm properistaltic jejunal segment was anastomosed to the side of the gallbladder, terminating as an end stoma for the collection and discard of bile. Eleven patients with hepatic insufficiency (or end-stage cirrhosis) received OLT using standard techniques, at the average age of 4 years. Six of the eight children treated with PBD had complete resolution of clinical symptoms and remain well 1 to 13 years postoperatively. These six patients have conjugated bilirubin values of less than 0.3 mg/dL, normal transaminases, and a serum bile salt concentration of less than 10 nmol/mL. All have had either reversal or no progression of the hepatic fibrosis. Postoperative bleeding complications occurred in two (25%), which required reoperation. One patient had an adhesive intestinal obstruction that was managed surgically 9 months postoperatively. Two patients had no benefit from PBD, and all of them had severe bridging fibrosis (1) or cirrhosis (3). These and nine others with cirrhosis at the time of presentation received orthotopic liver transplantation; of these, eight are alive (1 to 5 years postoperatively). These results show the importance of establishing a correct diagnosis in children with cholestasis. Clinical symptoms often are severe in children with PFIC before the development of irreversible hepatic fibrosis. Because several patients who appear to have been cured with PBD initially were scheduled for OLT, it is important that transplant surgeons recognize the feasibility of this approach.

Entities:  

Mesh:

Year:  1995        PMID: 8749912     DOI: 10.1016/0022-3468(95)90440-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  22 in total

1.  Partial internal biliary diversion for patients with progressive familial intrahepatic cholestasis type 1.

Authors:  Kyoko Mochizuki; Masayuki Obatake; Mitsuhisa Takatsuki; Akiko Nakatomi; Tomayoshi Hayashi; Sadayuki Okudaira; Susumu Eguchi
Journal:  Pediatr Surg Int       Date:  2012-01       Impact factor: 1.827

2.  Differences in presentation and progression between severe FIC1 and BSEP deficiencies.

Authors:  Ludmila Pawlikowska; Sandra Strautnieks; Irena Jankowska; Piotr Czubkowski; Karan Emerick; Anthony Antoniou; Catherine Wanty; Bjorn Fischler; Emmanuel Jacquemin; Sami Wali; Samra Blanchard; Inge-Merete Nielsen; Billy Bourke; Shirley McQuaid; Florence Lacaille; Jane A Byrne; Albertien M van Eerde; Kaija-Leena Kolho; Leo Klomp; Roderick Houwen; Peter Bacchetti; Steven Lobritto; Vera Hupertz; Patricia McClean; Giorgina Mieli-Vergani; Benjamin Shneider; Antal Nemeth; Etienne Sokal; Nelson B Freimer; A S Knisely; Philip Rosenthal; Peter F Whitington; Joanna Pawlowska; Richard J Thompson; Laura N Bull
Journal:  J Hepatol       Date:  2010-04-13       Impact factor: 25.083

3.  An outstanding non-transplant surgical intervention in progressive familial intrahepatic cholestasis: partial internal biliary diversion.

Authors:  F Gün; B Erginel; O Durmaz; S Sökücü; T Salman; A Celik
Journal:  Pediatr Surg Int       Date:  2010-06-20       Impact factor: 1.827

Review 4.  Liver transplantation and the management of progressive familial intrahepatic cholestasis in children.

Authors:  Ashley Mehl; Humberto Bohorquez; Maria-Stella Serrano; Gretchen Galliano; Trevor W Reichman
Journal:  World J Transplant       Date:  2016-06-24

Review 5.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

6.  Bile acid pool dynamics in progressive familial intrahepatic cholestasis with partial external bile diversion.

Authors:  Hilary S Jericho; Elizabeth Kaurs; Renze Boverhof; Alex Knisely; Benjamin L Shneider; Henkjan J Verkade; Peter F Whitington
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

Review 7.  Clinical aspects of familial cholestasis (with molecular explanations).

Authors:  K M Emerick; P F Whitington
Journal:  Curr Gastroenterol Rep       Date:  1999-06

Review 8.  Partial external biliary diversion for the treatment of intractable pruritus in children with progressive familial intrahepatic cholestasis: report of two cases.

Authors:  Saniye Ekinci; Ibrahim Karnak; Figen Gürakan; Aysel Yüce; Mehmet Emin Senocak; F Cahit Tanyel; Nebil Büyükpamukçu
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

9.  The cholecystocolic bypass with jejunal interposition graft for bile acid depletion in bile and portal blood in guinea pigs.

Authors:  A Delarue; M F Gerhardt; T Merrot; B Roquelaure; J M Guys; F Trivin
Journal:  Pediatr Surg Int       Date:  2003-07-05       Impact factor: 1.827

10.  Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis.

Authors:  Lee M Bass; Deepa Patil; M Sambasiva Rao; Richard M Green; Peter F Whitington
Journal:  BMC Gastroenterol       Date:  2010-03-13       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.